Overview
If you’re researching amyloid beta peptides, our Beta-Amyloid (1-40) • HFIP is a vital addition to your toolkit. This specially treated lyophilized Abeta-peptide undergoes HFIP treatment, which effectively dismantles any preexisting structures, delivering a dense and homogeneous preparation of unaggregated peptide. This is critical for controlled aggregation studies, particularly when examining the factors influencing neurodegenerative diseases.
Key Features
- HFIP treatment breaks down β-sheet structures in aggregated peptides.
- Promotes α-helical secondary structure for more consistent results.
- Provides samples that can be stored as peptide films.
- Ideal for use in neurological and physiological studies.
- Available for purchase as part of our extensive peptide catalog.
Specifications
| Product Name | CAS Number | Form | Storage Conditions |
|---|---|---|---|
| Beta-Amyloid (1-40) • HFIP | Applicable upon request | Lyophilized powder | -20°C, desiccated |
FAQ
What is the shelf life of Beta-Amyloid (1-40) • HFIP?
When stored properly at -20°C and desiccated, this product maintains its integrity for at least two years.
How should I prepare the peptide for use?
We recommend reconstituting the lyophilized peptide in an appropriate buffer to achieve the desired concentration for your experiments.
Can I use this peptide for aggregation studies?
Yes, the HFIP treatment enhances the peptide’s suitability for aggregation studies, allowing for reliable and reproducible results.
For researchers interested in exploring our full range of peptides, including options like PKG Substrate or peptide options such as Autocamtide-2we invite you to browse our selection. Enhance your research today with our high-quality peptide offerings.
Related Products
Browse more in Peptides.




Reviews
There are no reviews yet.